Approvals/TGA/SEQUASE XR quetiapine (as fumarate) 400 mg modified release tablet blister pack

Approved

STANDARD

SEQUASE XR quetiapine (as fumarate) 400 mg modified release tablet blister pack

Luye Pharma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2775f7961fb326d1
Product Name: SEQUASE XR quetiapine (as fumarate) 400 mg modified release tablet blister pack
Artg Id: 212515
Artg Name: SEQUASE XR quetiapine (as fumarate) 400 mg modified release tablet blister pack
Sponsor: Luye Pharma Australia Pty Ltd
Company Detail Path: /organization/luye-pharma-australia-pty-ltd
Artg Date: 2014-07-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/848741e4ac2cd81dabf05730bd31f602.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/84fd469195d9e48075f2625f8f94f5a9.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2775f7961fb326d1

Type

Standard